You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TPX-0131

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • TPX-0131
  • Orange, California
  • +13 more
Nov 7, 2022

Pregnancy Trial in Paris (standard-gamble technique, time trade-off technique)

Recruiting
  • Pregnancy
  • standard-gamble technique
  • time trade-off technique
  • Paris, France
    Groupe Hospitalier Paris Saint-Joseph
Jun 29, 2022

Stratification for Venous Thromboembolism in Hospitalized

Completed
  • Venous Thromboembolism
  • +6 more
    • Bern, Switzerland
    • +2 more
    Apr 4, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Irvine, California
    • +15 more
    Mar 9, 2022

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Oral repotrectinib (TPX-0005)
    • Yuma, Arizona
    • +175 more
    Jan 25, 2023

    Rotator Cuff Injuries Trial in Seongnam-si, Seoul (TPX-114, Arthroscopic surgery)

    Active, not recruiting
    • Rotator Cuff Injuries
    • TPX-114
    • Arthroscopic surgery
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    Jul 23, 2021

    Rotator Cuff Injuries Trial in Seongnam-si, Seoul (TPX-115, Placebo)

    Active, not recruiting
    • Rotator Cuff Injuries
    • TPX-115
    • Placebo
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    Jul 22, 2021

    Nasopharyngeal Cancer Trial in Guangzhou (Nab paclitaxel)

    Recruiting
    • Nasopharyngeal Cancer
    • Nab paclitaxel
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Apr 22, 2021

    Cartilage Morphology in Subjects Who Previously Received TPX-100

    Completed
    • Mild to Moderate Knee OA
    • Previous treated with TPX-100
    • Covina, California
      Dr. Samy Metyas
    Apr 4, 2018

    Knee Osteoarthritis Trial (TPX-100 200 mg 4 times weekly for 4 weeks)

    Completed
    • Knee Osteoarthritis
    • TPX-100 200 mg 4 times weekly for 4 weeks
    • (no location specified)
    Sep 18, 2017

    Knee Osteoarthritis Trial in Seattle (TPX-100 50mg, TPX-100 100mg, TPX-100 200mg)

    Completed
    • Knee Osteoarthritis
    • TPX-100 50mg
    • +4 more
    • Seattle, Washington
      C3 Clinical Research Associates
    Apr 19, 2017

    Nasopharyngeal Carcinoma Trial in Guangzhou (Docetaxel, Cisplatin 1, Xeloda)

    Unknown status
    • Nasopharyngeal Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 26, 2016